Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC lowered its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 79.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,260 shares of the company's stock after selling 88,606 shares during the period. SG Americas Securities LLC's holdings in Acadia Healthcare were worth $675,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Rhumbline Advisers grew its holdings in Acadia Healthcare by 4.6% during the fourth quarter. Rhumbline Advisers now owns 253,037 shares of the company's stock valued at $10,033,000 after purchasing an additional 11,033 shares during the period. State of New Jersey Common Pension Fund D grew its stake in shares of Acadia Healthcare by 59.2% during the 4th quarter. State of New Jersey Common Pension Fund D now owns 56,596 shares of the company's stock worth $2,244,000 after acquiring an additional 21,045 shares during the period. Oppenheimer Asset Management Inc. increased its holdings in Acadia Healthcare by 3.4% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 19,529 shares of the company's stock worth $774,000 after acquiring an additional 634 shares during the last quarter. US Bancorp DE raised its stake in Acadia Healthcare by 18.5% in the 4th quarter. US Bancorp DE now owns 15,196 shares of the company's stock valued at $603,000 after acquiring an additional 2,374 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its holdings in Acadia Healthcare by 9.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,234,223 shares of the company's stock valued at $48,937,000 after purchasing an additional 107,162 shares during the last quarter.

Wall Street Analysts Forecast Growth

ACHC has been the subject of several analyst reports. Guggenheim began coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 target price on the stock. KeyCorp decreased their target price on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Barclays dropped their price target on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research report on Wednesday, May 14th. Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Thursday, May 22nd. Finally, Bank of America cut their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research note on Friday, February 28th. Five investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, Acadia Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $47.94.

Acadia Healthcare Stock Performance

NASDAQ ACHC traded up $0.67 during trading hours on Tuesday, hitting $21.52. The company's stock had a trading volume of 1,327,581 shares, compared to its average volume of 1,783,778. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.35 and a quick ratio of 1.35. The company has a market cap of $1.98 billion, a P/E ratio of 10.60, a price-to-earnings-growth ratio of 4.04 and a beta of 0.94. The company's 50 day simple moving average is $23.02 and its two-hundred day simple moving average is $32.20. Acadia Healthcare Company, Inc. has a 12 month low of $20.36 and a 12 month high of $82.41.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a net margin of 5.94% and a return on equity of 8.72%. The business had revenue of $770.51 million for the quarter, compared to the consensus estimate of $769.90 million. During the same period last year, the firm earned $0.84 earnings per share. The company's quarterly revenue was up .3% on a year-over-year basis. As a group, sell-side analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.